Incorporating bio-based products and processes within traditional chemical districts BioLinX Workshop, 22.09.2016 Dr. Tatjana M. E. Schwabe, CLIB2021 e.v.
Cluster Industrial Biotechnology: CLIB2021 at a glance Investors & Founders Industry Open innovation cluster in industrial biotechnology and biobased economy Founded in 2008 Infrastructure Academia SME 100 members 50 % SME 30 % international > 70 bn EUR accumulated sales Cross-sector network (chemistry, energy, steel, forest, paper, plant construction, food & feed, agricultural, consumer products) International network with cluster core in Germany Supported by 06.10.2016 CLIB2021 2
Members Budget [T ] CLIB 2021 Development to date 120 800 100 80 Open Innovation 700 600 500 60 Internationalisation (members, offices, delegation trips) 400 40 20 Basic technologies (technology platforms and graduate cluster) Creation of network BioIndustry 2021 (BMBF) 300 200 100 0 2007 2008 2009 2010 2011 2012 2013 2014 2015 0 NRW Deutschland Germany EU Welt World Budget 06.10.2016 CLIB2021 3
Biotechnology today Drivers Alternative feedstocks CO 2 reduction Sustainability Increased efficiency Novel functionalities Hurdles High availability of fossil feedstocks Efficiency of petrochemical processes Lower TRL of biotechnological processes compared to petrochemical routes
CLIB 2021 Vision Establishing the bio- and circular economy in industry 06.10.2016 CLIB2021 5
Challenges on the way to commercialisation Viable business models Accessible product spectrum Low oil price Economic feasibility Process concepts for biotech Missing process experience Inadequate process efficiency
Challenges on the way to commercialisation Viable business models Low oil price Economic feasibility Optimisation potential Missing process experience Accessible product spectrum Process concepts for biotech Inadequate process efficiency
Compatibility of feedstock, process, and target market Bulk chemicals Fine chemicals & specialties
TRL markets Viable business cases to enable novel value chains Focus drop-in fuels bulk chemicals Focus new functionalities fine chemicals specialities lab pilot demo pre-commercial commercial 2 years 5 years 15 years 25 years 06.10.2016 CLIB2021 9
Fuels & Energy Bulk chemicals Target markets long-term market Personal & Home Care Cosmetics Detergents Flavours and fragrances Food, Feed & Nutrition Food Feed Nutraceuticals Supplements Crop Protection Plant breeding Flavours High Performance Materials Textiles (fibres) Adhesives Packaging Functionalised surfaces long-term market Process technology Education Auxilliaries (enzymes, acids, surfactants) Reactor systems Analytics Interdisciplinary Cross-border Applied 06/10/2016 CLIB2021 10
Industry Academia Industry Academia Process industry brand owners CLIB 2021 Strategy: Structured networking process Identification of suitable feedstocks & suppliers Education Identification of market needs Feedstock Conversion technologies Product R&D to develop technologies & value chains
Industry Academia Industry Academia Process industry Consumer brnads CLIB 2021 Strategy: Structured networking process HiPerIn Identification of suitable feedstocks & suppliers Education Education Identification of market needs Feedstock Conversion technologies Product R&D to develop technologies & value chains HiPerIn
CLIB 2021 Strategy: Structured networking process Participants 180 CLIB Conference 50 CLIB Forum Events 20 CLIB Round Table Bilateral Talks Level of detail/confidentiality
Workflow Market-focused technology development: Workflow BIG-C Aim: Connecting international clusters from NRW, Flanders and The Netherlands Networking stakeholders, competences and projects Generating critical mass for pilot and demo plants to implement new technologies in the region Exemplified by implementation of value chains C1 and bio-aromatics Kick-off More than 60 participants; talks by Biobased Delta, Covestro, Thyssen and VITO Identification of interested stakeholders Working Group Meeting ca. 20 participants in each workshop, talks by LanzaTech, Photanol and Scion Identification of necessary expertise, definition of parameters for novel value chains Follow-Up Identification of the optimal combination of product & technology platform Selection of target products together with industrial partners (e.g. Covestro) Next step: Definition of concrete project topics
CLIB & Henkel CLIB member since 2008 Good fit with biobased activities Diverse partnering opportunities Professional cluster work, internationalisation Internships (CLIB-Graduate Cluster Industrial Biotechnology) Example: Adhesive peptides project Partners: Identified and characterised several selectively binding dodecapeptides Peptide-polymer bioconjugates tested Development towards commericalisation, collaboration with Numaferm* *start-up by alumnus of the CLIB-GC
Market-focused technology development: Example Henkel CLIB Forum Highly functional biobased molecules for adhesives 13 August 2015 45 participants Talks by Fraunhofer UMSICHT, Jowat, Henkel and Wageningen University Presentation of technical advances through of biotechnology and market needs from industry 1 st Round Table Adhesives on 20.10.2015 Focused list of participants from 10 organisations Presentation of competence profiles Henkel provided concrete needs 2 nd Round Table Adhesives on 11.01.2016 Hand-picked participants from 6 organisations. Discussion about concrete collaborations (confidential) Initiation of bilateral projects (e.g. Numaferm) 06/10/2016 CLIB2021 16
HiPerIn - High Performance Ingredients 17
Start-Up Support CLIB supports Start-ups and Spin-offs: Autodisplay Biotech Spin-off from HHU Düsseldorf, founder team via CLIB Advised by Dr. Kircher Pep2Express/Numaferm Coaching by Dr. Schwarz SenseUp Spin-off from FZ-Jülich, coaching by Dr. Schwarz Support of technology transfer from universities and companies via CLIB and/or b.experts GmbH 18
Added values CLIB 2021 Added values Integration into an international network of academia, investors, SME and Industry Knowledge building regarding relevant topics, markets, technologies and development trends in biotechnology and clean technologies Access to highly-qualified, interdisciplinary-trained specialists in the field of biology, chemistry and engineering Creating novel business models through formation of networks and value chain analysis in biotechnology and clean technologies Formation of tailored consortia (intersectoral, national & international) and, therefore, higher success rate in terms of project acquisition Information on current calls and strategy processes (regional, national, European, international) in the field of bioeconomy and circular economy Supporting demo and pilot projects of biotech technologies and processes 06.10.2016 CLIB2021 19
Thank you! Contact: Dr. Tatjana Schwabe schwabe@clib2021.de 20